Project Grant HT94252310158
Award Date
2/23/23
Completion Date
2/22/27
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Augusta, GA 30912, USA
Similar Awards
The Department of the Army Medical Command awarded a $1,155,000 Project Grant to Augusta University Research Institute, Inc. under the Military Medical Research and Development program. The grant will fund research from June 2022 to May 2025 to sensitize prostate cancer to ferropotosis-based therapy. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award supports the program's goal by...
Augusta University Research Institute, Inc. (AURI), a subsidiary of the Board of Regents of the University System of Georgia, received a $808,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program. The three-year award will support AURI's research into the role of neurofibromin 2 (NF2) in vascular smooth muscle cells. NF2 mutations have been linked to various cancers, and this project will investigate medical solutions for conditions...
This Project Grant award of $769,134.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Augusta University Research Institute, Inc. (AURI) to investigate the role of CXC chemokine ligand 8 in modulating cadmium-induced prostate carcinogenesis. The grant period runs from August 1, 2023 to July 31, 2026. AURI is a non-profit organization and subsidiary of the Board of Regents of the University System of Georgia, which has...
The Defense Health Agency awarded a $1,346,633 Project Grant to the George Washington University under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research titled "A PRIMARY ROLE FOR THE CIRCULATORY MICROENVIRONMENT IN AFRICAN AMERICAN PROSTATE CANCER DISPARITIES?" from May 15, 2023 to May 14, 2026. As the prime awardee, George Washington University will investigate medical solutions for prostate cancer disparities affecting African...
The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,331,869.00 to Emory University to conduct research on "Therapeutic Targeting of Aurora Kinase A in Lethal Prostate Cancer Using a Novel Inhibitor". The three-year project aims to investigate medical solutions for the battlefield through innovative biomedical research. Emory University is the prime awardee, and they have subcontracted a portion of...
Emory University will conduct research under a $1,255,611 Project Grant from the Defense Health Agency through the Military Medical Research and Development program. The three-year award beginning in April 2023 will fund research to define the molecular basis for immunogenicity of locally advanced prostate tumors resistant to androgen deprivation therapy. The CFDA 12.420 program supports basic, applied and advanced biomedical research to transform military and public health care through...
The Department of Defense's Defense Health Agency awarded a $685,778 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Georgia Research Foundation, Inc. This federal grant, titled "Endoplasmic Reticulum-Targeted Radiodynamic Therapy for the Treatment of Lung Cancer," will fund research from July 2024 through July 2027. The University of Georgia Research Foundation is the prime recipient and will collaborate with Emory...
The Department of Defense's Defense Health Agency awarded Duke University a $1,344,946 Project Grant on September 1, 2023 through the Military Medical Research and Development program (CFDA 12.420). This grant supports a 3-year research project titled "Understanding Heterogeneity and Improving the Precision of Prostate Cancer Clinical Outcomes in the Modern Era." The research aims to advance understanding and treatment of prostate cancer, with a focus on improving clinical outcomes for...
The U.S. Defense Health Agency awarded a $1,513,169 Project Grant to Health Research, Inc. to support the "LEVERAGING POLYAMINE METABOLISM TO TARGET EPIGENOMIC ADAPTABILITY AND LINEAGE PLASTICITY IN PROSTATE CANCER" research project under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, beginning on April 1, 2024, aims to develop innovative approaches for treating prostate cancer by targeting tumor metabolism and epigenetic mechanisms. As a...